Everence Capital Management Inc. and
Principal Financial Group Inc. have increased their stakes in
Laboratory Co. of America Holdings (NYSE:LH), while
JPMorgan Chase & Co. currently holds a $431.41 million stake. However,
Tidal Investments LLC and
M&T Bank Corp have sold their shares.
Labcorp's Q2 2024 earnings reported an EPS of $2.43, surpassing estimates, and a quarterly dividend has been declared. The firm is considering increasing
mpox testing capacity and made a cosmetic change. Labcorp's
stock reached a 52-week high at $238.93, showing a robust growth. Alliances have been announced with
Legacy Health,
Baystate Health, and
Tufts Medicine, along with the acquisition of select assets from Invitae and BioReference Health's diagnostics business. The company also completed a
spin-off of Fortrea. However, a class-action lawsuit claims that Labcorp overcharges patients for tests.
Laboratory Corporation of America Holdings LH News Analytics from Wed, 05 Nov 2014 08:00:00 GMT to Sat, 04 Jan 2025 09:12:21 GMT -
Rating 6
- Innovation -1
- Information 8
- Rumor -3
